998个保健计划中,有11个在2025年NCQA审查中获得了最高的5星级评分,是去年的两倍。 
Eleven of 998 health plans earned top 5-star ratings in 2025 NCQA review, double last year’s total.
NCQA的2025年健康计划评级利用包括HEDIS、CAHPS和HOS在内的近50项措施,评价商业、医疗福利和医疗补助临床质量和病人经验计划。 The NCQA's 2025 Health Plan Ratings evaluate commercial, Medicare Advantage, and Medicaid plans on clinical quality and patient experience using nearly 50 measures, including HEDIS, CAHPS, and HOS. 998个计划中有11个计划赚取了5个恒星——去年增加了一倍以上——55个计划获得4.5个恒星。 Eleven of 998 plans earned 5 stars—more than double last year—while 55 received 4.5 stars. 新的成员语言多样性衡量标准评估了收集语文数据以减少差异的计划努力。 A new Language Diversity of Membership measure assesses plans’ efforts to collect language data to reduce disparities. 在医疗保健服务的过渡、糖尿病和肾脏保健以及免疫率等方面都取得了重大改善。 Key improvements were seen in Medicare care transitions, diabetes and kidney health, and immunization rates. 评级反映了2024年的数据,2023年的《医疗保健计划》的一些衡量标准为2023年的数据。 Ratings reflect 2024 data, with some Medicare metrics from 2023.
